These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4542790)

  • 21. [Clinical study with a new antihyperlipemic combination].
    Pistautz H
    Arzneimittelforschung; 1977; 27(1):152-6. PubMed ID: 576816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do fats matter.
    Jepson EM
    Trans Med Soc Lond; 1972; 88():12-21. PubMed ID: 4665812
    [No Abstract]   [Full Text] [Related]  

  • 23. Chlorophenoxyisobutyric acid derivatives and apolipoprotein B metabolism.
    Shepherd J; Packard CJ
    Monogr Atheroscler; 1985; 13():85-91. PubMed ID: 4088282
    [No Abstract]   [Full Text] [Related]  

  • 24. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
    Bavina MV; Perova NV; Lobova NM; Koropova GI
    Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180
    [No Abstract]   [Full Text] [Related]  

  • 25. [Increased thrombocyte aggregation in essential hyperlipemia].
    Renzenbrink J; Holzknecht F; Braunsteiner H
    Acta Haematol; 1967; 38(2):95-103. PubMed ID: 4963579
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
    Dimroth H
    Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of hyperlipemia].
    Condorelli S; Patanè F; Lombardi D
    Boll Soc Ital Cardiol; 1975; 20(11):1457-66. PubMed ID: 1234444
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative studies on the reduction of lipids using clofibric acid and clofibrate in hyperlipoproteinemias].
    Schwartzkopff W; Hoffmann H; Kästner W
    Med Welt; 1975 Dec; 26(51):2308-15. PubMed ID: 177837
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U; Johannes KJ
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
    Krut LH; Seftel HC; Joffe BI
    S Afr Med J; 1977 Mar; 51(11):348-52. PubMed ID: 323994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic hyperlipemia with thalassemia major: report of two cases.
    Desai M; Akruwala S; Babar ST
    Indian Pediatr; 1973 Aug; 10(8):511-6. PubMed ID: 4763968
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gout and hyperlipemia].
    Günther R; Herbst M; Knapp E
    Wien Klin Wochenschr; 1967 Mar; 79(12):218-21. PubMed ID: 5585987
    [No Abstract]   [Full Text] [Related]  

  • 33. [Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
    Singer P; Gnauck G; Honigmann G; Thoelke H; Schliack V; Läuter J
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(1):27-37. PubMed ID: 913315
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
    Wilke H; Frahm H
    Dtsch Med Wochenschr; 1976 Mar; 101(11):401-5. PubMed ID: 1253701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New drug combination for medical management of hyperlipemia: clinical study].
    Fischer M; Falkensammer C
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
    [No Abstract]   [Full Text] [Related]  

  • 37. [Essential hyperlipemia and decreased fibrinolysis activity].
    Spöttl F; Holzknecht F; Braunsteiner H
    Acta Haematol; 1967; 38(3):180-3. PubMed ID: 4963585
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
    Hammerl H; Nebosis G; Pichler O; Studlar M
    Med Welt; 1973 Mar; 24(12):468-70. PubMed ID: 4700881
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
    MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT
    Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.